Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC trimmed its holdings in shares of Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) by 2.9% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 202,680 shares of the company’s stock after selling 6,005 shares during the period. Rice Hall James & Associates LLC’s holdings in Consensus Cloud Solutions were worth $3,482,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in CCSI. Charles Schwab Investment Management Inc. raised its stake in shares of Consensus Cloud Solutions by 13.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 269,965 shares of the company’s stock worth $7,076,000 after buying an additional 31,433 shares during the period. Trexquant Investment LP acquired a new position in Consensus Cloud Solutions in the 4th quarter valued at $923,000. Aristides Capital LLC acquired a new position in Consensus Cloud Solutions in the 4th quarter valued at $252,000. PNC Financial Services Group Inc. raised its stake in Consensus Cloud Solutions by 132.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,691 shares of the company’s stock valued at $44,000 after purchasing an additional 962 shares during the last quarter. Finally, Bridge City Capital LLC raised its stake in Consensus Cloud Solutions by 2.2% in the 1st quarter. Bridge City Capital LLC now owns 57,577 shares of the company’s stock valued at $913,000 after purchasing an additional 1,245 shares during the last quarter. 93.93% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently commented on CCSI shares. BTIG Research raised Consensus Cloud Solutions from a “neutral” rating to a “buy” rating and set a $30.00 price objective for the company in a research note on Wednesday, August 21st. Oppenheimer increased their price objective on Consensus Cloud Solutions from $20.00 to $23.00 and gave the company an “outperform” rating in a research note on Friday, August 9th. Finally, JPMorgan Chase & Co. downgraded Consensus Cloud Solutions from a “neutral” rating to an “underweight” rating and increased their price objective for the company from $19.00 to $21.00 in a research note on Monday. Two equities research analysts have rated the stock with a sell rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $23.60.

Consensus Cloud Solutions Stock Down 1.2 %

Shares of CCSI opened at $21.56 on Thursday. Consensus Cloud Solutions, Inc. has a 52-week low of $11.62 and a 52-week high of $28.09. The company has a market capitalization of $414.38 million, a PE ratio of 4.76 and a beta of 1.38. The stock has a fifty day simple moving average of $20.57 and a two-hundred day simple moving average of $17.48.

Consensus Cloud Solutions (NASDAQ:CCSI) last released its quarterly earnings results on Thursday, August 8th. The company reported $1.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.15. The business had revenue of $87.50 million during the quarter, compared to analysts’ expectations of $87.10 million. Consensus Cloud Solutions had a negative return on equity of 57.77% and a net margin of 25.72%. As a group, equities analysts anticipate that Consensus Cloud Solutions, Inc. will post 4.47 earnings per share for the current fiscal year.

Consensus Cloud Solutions Profile

Consensus Cloud Solutions, Inc, together with its subsidiaries, provides information delivery services with a software-as-a-service platform worldwide. The company offers eFax Corporate, a digital cloud-fax technology; Unite, a single platform that allows the user to choose between various protocols to send and receive healthcare information and can integrate into an existing electronic health record system or stand-alone if no EHR is present.